[go: up one dir, main page]

MXPA03001540A - 4-fenil-1-(1-fienl-ciclohexil)-1,2,3,6-tetrahidro-piridina sustituida. - Google Patents

4-fenil-1-(1-fienl-ciclohexil)-1,2,3,6-tetrahidro-piridina sustituida.

Info

Publication number
MXPA03001540A
MXPA03001540A MXPA03001540A MXPA03001540A MXPA03001540A MX PA03001540 A MXPA03001540 A MX PA03001540A MX PA03001540 A MXPA03001540 A MX PA03001540A MX PA03001540 A MXPA03001540 A MX PA03001540A MX PA03001540 A MXPA03001540 A MX PA03001540A
Authority
MX
Mexico
Prior art keywords
phenyl
tetrahydropyridine
cyclohexyl
substituted
Prior art date
Application number
MXPA03001540A
Other languages
English (en)
Inventor
Michael Sattlegger
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MXPA03001540A publication Critical patent/MXPA03001540A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MXPA03001540A 2000-09-08 2001-09-05 4-fenil-1-(1-fienl-ciclohexil)-1,2,3,6-tetrahidro-piridina sustituida. MXPA03001540A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10044649A DE10044649A1 (de) 2000-09-08 2000-09-08 Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
PCT/EP2001/010224 WO2002020481A2 (de) 2000-09-08 2001-09-05 Substituierte 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine

Publications (1)

Publication Number Publication Date
MXPA03001540A true MXPA03001540A (es) 2003-06-06

Family

ID=7655648

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001540A MXPA03001540A (es) 2000-09-08 2001-09-05 4-fenil-1-(1-fienl-ciclohexil)-1,2,3,6-tetrahidro-piridina sustituida.

Country Status (17)

Country Link
US (1) US7034041B2 (es)
EP (1) EP1315700B1 (es)
JP (1) JP2004508353A (es)
AR (1) AR035489A1 (es)
AT (1) ATE344244T1 (es)
AU (2) AU1048602A (es)
CA (1) CA2421835A1 (es)
DE (2) DE10044649A1 (es)
DK (1) DK1315700T3 (es)
ES (1) ES2275740T3 (es)
HU (1) HUP0303676A2 (es)
MX (1) MXPA03001540A (es)
NZ (1) NZ525144A (es)
PE (1) PE20020369A1 (es)
PL (1) PL366065A1 (es)
PT (1) PT1315700E (es)
WO (1) WO2002020481A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10360793A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US8268866B2 (en) 2004-03-29 2012-09-18 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US20060063802A1 (en) 2004-03-29 2006-03-23 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US9072662B2 (en) 2004-03-29 2015-07-07 Auris Medical Ag Methods for the treatment of tinnitus induced by cochlear excitotoxicity
KR101271263B1 (ko) 2005-09-28 2013-06-07 아우리스 메디칼 아게 내이 장애 치료용 약학 조성물
ES2862673T3 (es) 2011-12-12 2021-10-07 Zilentin AG Tratamiento del tinnitus mediante la modulación del cotransportador de cloruro NKCC1 en el sistema auditivo
ES2772689T3 (es) 2015-10-15 2020-07-08 Jiangsu Hengrui Medicine Co Derivado de oxa espiro, método de preparación del mismo y aplicaciones del mismo en medicamentos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1

Also Published As

Publication number Publication date
PE20020369A1 (es) 2002-05-18
US7034041B2 (en) 2006-04-25
PT1315700E (pt) 2007-01-31
US20030225116A1 (en) 2003-12-04
HUP0303676A2 (hu) 2004-03-01
WO2002020481A3 (de) 2002-07-18
ATE344244T1 (de) 2006-11-15
DK1315700T3 (da) 2007-02-19
AU2002210486B2 (en) 2006-06-01
PL366065A1 (en) 2005-01-24
EP1315700A2 (de) 2003-06-04
CA2421835A1 (en) 2003-03-07
WO2002020481A2 (de) 2002-03-14
EP1315700B1 (de) 2006-11-02
DE10044649A1 (de) 2002-07-04
JP2004508353A (ja) 2004-03-18
ES2275740T3 (es) 2007-06-16
AR035489A1 (es) 2004-06-02
AU1048602A (en) 2002-03-22
DE50111385D1 (de) 2006-12-14
NZ525144A (en) 2006-01-27

Similar Documents

Publication Publication Date Title
MXPA03009000A (es) Compuestos benzo-fusionados 1,4-disustituidos.
MXPA03003529A (es) Compuestos de piperidina como antialergicos.
ZA200204395B (en) Selective neurokinin antagonists.
ZA200400077B (en) Fuse box.
ZA200108867B (en) Piperidine derivatives useful as CCR5 antagonists.
MXPA03005743A (es) Antagonistas muscarinicos.
AU3740101A (en) 2,4-disubstituted thiazolyl derivatives
ZA9610885B (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives.
ZA99314B (en) 4-(2-Keto-1-Benzimidazolinyl)piperidine compounds as orl1-receptor agonists.
MXPA03002938A (es) Maquina herramienta.
MXPA03004292A (es) Compuesto de lactama.
MXPA03006991A (es) Derivados de piperidina como antagonistas de neurocinina 1.
HUP9904622A3 (en) 1,4-di-sustituted piperidines as muscarinic antagonists
CY2271B1 (en) 1.(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
IL154467A0 (en) 1,4-disubstituted benzenes as insecticides
ZA200201789B (en) Substituted pyrrolidin-2,3,4-trion-3-oxime drivatives useful as NMDA-receptor antagonists.
MXPA03001540A (es) 4-fenil-1-(1-fienl-ciclohexil)-1,2,3,6-tetrahidro-piridina sustituida.
AU2002210486A1 (en) Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
MXPA03002117A (es) Composiciones fungicidas.
DK1119571T3 (da) Tricykliske Delta 3 piperidiner som alpha 2 antagonister.
ZA200201036B (en) 1,4-substituted 4,4-diaryl cyclohexanes.
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
ZA200005697B (en) Paroxetine compositions.
SI1315700T1 (sl) Substituirani 4-fenil-1-(1-fenil-cikloheksil)-1,2,3,6-tetrahidropiridini
HK1056874A (en) Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine

Legal Events

Date Code Title Description
FG Grant or registration